NASDAQ, originally known as the National Association of Securities Dealers Automated Quotations, is a stock market exchange based in New York that enables investors to buy and sell stocks on an automatic electronic platform. It is the world’s second-largest stock exchange market in the world. It is also the world’s largest and first completely online stock market. NASDAQ trades in many companies like capital goods, consumer durables and non-durables, finance, energy, healthcare, technology, transportation, high-tech stocks, and more. A market maker deals with a specific stock and holds a certain amount of stock in their books. When a client wants to buy shares, they do it from the market maker. The listing fee of NASDAQ is set at a maximum price of $150000, which is considerably lower than the price at other stock markets. NASDAQ: AEMD at https://www.webull.com/quote/nasdaq-aemd provides data on the stocks, recent updates, latest news, etc.
About AEMD
Aethlon Medical Inc. (AEMD) aims to develop medical devices that combat infectious diseases and cancer with immunotherapeutic technologies. Its most popular product, the Aethlon Hemopurifier, reduces the presence of viruses in the patient hence enhancing the body’s natural immunity. The company is currently trying to discover the potential use of the Hemopurifier to reduce the presence of exosomes that are derived from the tumor. The company aims to address needs that are not met in biodefense and global health. The company has a market capitalization of $18.83 million. The provider of the medical equipment gains $1.87 as earnings per share.
Stock Summary
The revenue at Aethlon Medical has grown by about 463.81% in a year, beating 98.41% of US stocks. The amount of capital returned to shareholders through dividends and buybacks is also greater than that of 4.12% of US stocks. The company’s current price for shares in the stock market is $1.57 and its previous close was for $1.59. The company’s 52-week high was recorded as $6.30. The company’s annual sale is recorded as $650,000. Its price-to-sale ratio is 28.97.
At the end of the previous quarter in June, the company had a cash balance of $15.7 million. The average expense for three months is $1.5 million. In June 2020, NASDAQ: AEMD also raised cash through the sale of 2,685,600 shares of common stock. They received an aggregate net of approximately 7.3 million USD. It has an average daily volume of 1,660,000 shares, thus making the days-to-cover ratio 0.3 days.
Shares of Aethlon Medical Inc. can be bought through any online brokerage account. Clients are highly advised to do their share of research before buying a share of any company. If you want to know how to buy stocks, you can check at online trading sites. Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
